CVAC Competitors & Alternatives
Compare CureVac NV with similar stocks in the same industry
Biotechnology
CVAC
Main Stock$4.66
Tradestie Score
58
Market Cap
$1.22B
P/E Ratio
7.0
Revenue Growth
-0.9%
Analyst Upside
+15.6%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NKTR
Nektar Therapeutics
|
$60.61
|
$1.12B | - | 52 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$265.32
|
$1.12B | - | 55 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.39
|
$1.09B | - | 52 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$12.82
|
$1.05B | 67.8 | 55 | Compare |
|
MDXG
MiMedx Group, Inc
|
$3.69
|
$1.01B | 18.5 | 63 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$9.85
|
$997.16M | - | 59 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$2.88
|
$996.55M | - | 53 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$82.93
|
$994.20M | - | 60 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.40
|
$993.46M | - | 47 | Compare |
|
IMNM
Immunome, Inc.
|
$18.21
|
$987.09M | - | 57 | Compare |
More CVAC Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry